IMPACT OF TIMING OF 4F-PCC ADMINISTRATION ON OUTCOMES IN ORAL FACTOR XA INHIBITOR-ASSOCIATED ICH

被引：0
|
作者：
Jaszcz, Sarah [1 ]
Wein, Rachel [1 ]
Mangan, Kyle
Mohamed, Wazim [2 ]
Parker, Dennis [3 ]
机构：
[1] DETROIT MED CTR, DETROIT, MI USA
[2] Wayne Hlth, Greenville, OH USA
[3] Wayne State Univ, Detroit Med Ctr, Detroit, MI USA
来源：
CRITICAL CARE MEDICINE | 2025年 / 53卷 / 01期
关键词：
D O I：
10.1097/01.ccm.0001104104.33520.99
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] TIME TO 4F-PCC AND BLOOD PRESSURE CONTROL IN FACTOR XA INHIBITOR-ASSOCIATED INTRACEREBRAL HEMORRHAGE
    Vilar, Jason
    Priano, James
    Rzasa, Kaitlin
    CRITICAL CARE MEDICINE, 2020, 48
  • [2] IMPACT OF FIXED-DOSE 4F-PCC VERSUS WEIGHT-BASED 4F-PCC FOR FACTOR XA INHIBITOR MAJOR BLEEDING
    Ioppolo, Lacey
    Rottman, Kathleen
    Cannon, Chad
    Hayes, Sarah
    Allen, Bryan
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 159 - 159
  • [3] EVALUATION OF 4F-PCC IN THE MANAGEMENT OF MAJOR BLEEDING ASSOCIATED WITH ORAL FACTOR XA INHIBITORS
    Deloney, Lindsay
    Tatum, Cassandra
    Weant, Kyle
    Eriksson, Evert
    Smith, Melanie
    CRITICAL CARE MEDICINE, 2019, 47
  • [4] Comparison of 4F-PCC and aPCC time to administration and outcomes for oral anticoagulant-related ICH
    Lin, Stacy
    Cunningham, Brittany
    Mullen, Chanda
    Simon, Erin
    Bice, Deanna
    Garlock, Jenna
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 2022, 56 : 183 - 187
  • [5] Clinical Outcomes of Oral Factor Xa-Inhibitor Associated Gastrointestinal Bleeds Treated with or without 4F-PCC among US Medicare Patients
    Williams, J.
    Coleman, C., I
    McNeil-Posey, K.
    Dettling, T.
    Li, S.
    Guo, H.
    Hoover, M.
    ANNALS OF EMERGENCY MEDICINE, 2020, 76 (04) : S27 - S27
  • [6] FIXED-DOSE 4F-PCC FOR REVERSAL OF FACTOR XA INHIBITOR FOR INTRACRANIAL HEMORRHAGE
    Anderson, Whitney
    Middleton, Grant
    Svelund, Elizabeth
    CRITICAL CARE MEDICINE, 2025, 53 (01)
  • [7] Comparison of Low- Versus High-Dose Four-Factor Prothrombin Complex Concentrate (4F-PCC) for Factor Xa Inhibitor-Associated Bleeding: A Retrospective Study
    Wilsey, H. Andrew
    Bailey, Abby M.
    Schadler, Aric
    Davis, George A.
    Nestor, Melissa
    Pandya, Komal
    JOURNAL OF INTENSIVE CARE MEDICINE, 2021, 36 (05) : 597 - 603
  • [8] FOUR-FACTOR PCC VERSUS ANDEXANET ALFA FOR ORAL FACTOR XA INHIBITOR-ASSOCIATED MAJOR BLEEDS
    Kafka, Wesley
    Nowling, Anthony
    Patel, Apexa
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 194 - 194
  • [9] EVALUATION OF 4F-PCC IN OBESE VERSUS NON-OBESE PATIENTS FOR FACTOR XA INHIBITOR REVERSAL
    Ciborowski, Megan
    Nakajima, Steven
    Sparks, Eric
    McKinney, James, III
    CRITICAL CARE MEDICINE, 2020, 48
  • [10] EVALUATION OF FIXED-DOSE VERSUS WEIGHT-BASED DOSING OF 4F-PCC FOR ORAL FACTOR XA INHIBITOR BLEEDING
    Ellenburg, Jessica
    Beck, Julie
    Casey, Jessica
    Kallenberger, Michael
    John, Jeremy
    Musselman, Megan
    CRITICAL CARE MEDICINE, 2024, 52
12345